eXoZymes (EXOZ) Stock Price, News & Analysis

Company Overview

eXoZymes, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.

Key Stats

• Today's Range: $9.30 to $9.35
• 50-Day Range: $9.15 to $12.69
• 52-Week Range: $8.50 to $23.99
• Volume: 794 shs
• Average Volume: 1,803 shs
• Market Capitalization: $78.11 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EXOZ Stock Analysis - Frequently Asked Questions

How have EXOZ shares performed this year?

eXoZymes' stock was trading at $17.39 at the beginning of the year. Since then, EXOZ shares have decreased by 46.5% and is now trading at $9.31.

How were eXoZymes' earnings last quarter?

eXoZymes Inc. (NASDAQ:EXOZ) issued its earnings results on Tuesday, August, 12th. The company reported ($0.28) earnings per share (EPS) for the quarter.
Read the conference call transcript.

How do I buy shares of eXoZymes?

Shares of EXOZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/12/2025
• Today: 8/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:EXOZ
• CIK: 2010788
• Web: N/A
• Phone: (626) 415-1488
• Fax: N/A
• Employees: 29
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$5.86 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -134.50%
• Return on Assets: -81.63%

Debt

• Debt-to-Equity Ratio: 0.01
• Current Ratio: 6.19
• Quick Ratio: 6.19

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.86 per share
• Price / Book: 10.83

Miscellaneous

• Outstanding Shares: 8,387,000
• Free Float: 2,314,000
• Market Cap: $78.08 million
• Optionable: N/A
• Beta: N/A